HL7 Medication and UKCPRS Julie James Partner Blue Wave Informatics.

Slides:



Advertisements
Similar presentations
HL7 V3 – the Medication Information/Pharmacy Domain
Advertisements

UKCPRS Drug Dictionary Project Update for HL7 Autumn 2002 Julie James/Paul Frosdick Blue Wave Informatics / NHS Information Authority.
Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.
Kate Fox Commercial Manager BCM Specials Ltd. Conditions of manufacture and supply of unlicensed medicinal products Bona fide unsolicited order Product.
The Pharmaceutical Agent Order. Prescription An oral or written record of a physicians order to pharmacist to dispense medication to patient.
Electronic Medication Management (eMM) Dr Stephen Chu Chief Clinical Informatician & Terminologist Clinical Terminology & Information, NEHTA Landscape.
VTM Virtual Therapeutic Moeity Actual Therapeutic Moeity ATM VMP Virtual Medicinal Product AMP Actual Medicinal Product AMPP Actual Medicinal Product Package.
Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health Update on barcodes.
Vive la différence? Dose Vs Product Dose instructions syntax Dr Paul Miller
Webinar : An introduction to NHS dm+d and SNOMED CT UK Drug Extension
NHS Connecting for Health is delivering the National Programme for Information Technology ePrescribing update Ann Slee Clinical Lead ePrescribing programme,
Chapter 17: Institutional Pharmacy Jeffery D. Evans, Pharm.D. Associate Professor of Pharmacy Practice.
WG 6 «Pharmacy & Medication» Current activities Porto, Wednesday 11th June 2014.
 Definition of medicines management  Incidents reported  How medications errors are reported  Actions taken to prevent reoccurrence  Role of the.
Dr Libby Morris and Dr Ian Thompson SCIMP March 2013.
10/05/ PDIG Award 2008/9: Purchasing for Safety – Injectable Medicines Dr Clare Crowley Lead Medicines Safety Pharmacist Oxford Radcliffe Hospitals.
EPharmacy Programme: the electronic Acute Medication Service (eAMS) ePharmacy Programme: the electronic Acute Medication Service (eAMS)
Preventing Medication Errors Chapter 9. 2 Safe Medication Administration Prescription –Licensed providers must have authority within their state to write.
GOOD PHARMACY PRACTICE
HL7 Drug Name Coordination Efforts James J. Cimino, M.D. Columbia University.
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
New ISO projects Joint meeting HL7, IHE and ISO Pharmacy groups Leonora Grandia, Z-Index.
 Overview The Drug Compendia  Review Drug Compendia Processes  Benefits of SPL.
Pharmacy Administration Issues and thoughts Jürgen Brandstätter.
The Evolution of Pharmacy Messages HL7 UK Conference 2 November 2004 Hugh Glover, BSc, PhD Partner, Blue Wave Informatics LLP
Pharmacy Administration Issues and thoughts Jürgen Brandstätter.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Downstream Use of Structured Product Labeling Thomas R. Bizzaro, R.Ph. Vice President, Health policy and Industry Relations SPL/DailyMed Jamboree Workshop.
Spiro Consulting Overview of Technology Approaches of Medication Management in Long-Term Care Rachelle “Shelly” Spiro, RPh, FASCP President, Spiro Consulting.
The EHR-S FIM project plans to harmonize the EHR-S FM R2
1CDISC 2002 RCRIM – Standard Domains Agenda NCI Presentation Standard Domains Working Group Goals Introduction to FDA Information Model (FIM) Discussion:
HL7 HL7  Health Level Seven (HL7) is a non-profit organization involved in the development of international healthcare.
Dispensing &compounding Prepared by: Kazi Rashidul Azam.
Terminology and HL7 Dr Colin Price HL7 UK 11 th December 2003.
OR “READ THE FINE PRINT PLEASE!”
TECHNICAL REQUIREMENTS FOR MINOR APPLICATIONS E MOKANTLA 3 SEPTEMBER 2013.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Calculating Oral Dosage
Julie James, MRPharmS Chair Pharmacy Sub-Group Partner, Blue Wave Informatics LLP October 2006© Blue Wave Informatics.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Commentary: The HL7 Reference Information Model as the Basis for Interoperability George W. Beeler, Jr. Ph.D. Co-Chair, HL7 Modeling & Methodology.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
Federal Medication Terminologies (FMT) Enabling Health IT Interoperability.
Methotrexate Never Event Presentation Date November 2015 Christine Dodd Medication Safety Pharmacist Martin Shepherd Medicines Information & Clinical Economy.
When Supply Chain meets Care Delivery: Background on GS1 and HL7 Ulrike Kreysa Director Healthcare, GS1 Global Office.
1 Structured Product Labeling Project Update Randy Levin, M.D. Director for Health and Regulatory Data Standards Food and Drug Administration HL7 Working.
Medication POD. Take a moment to do the following: Tell people where the restrooms are located Point out location of break area Go over the lunch and.
Dispelling the myths about dm+d Presenter: Karen ReesDate: 10 th December 2014 dm+d and the NHS Standard.
Medication data in patient summaries
Implementing the NHS dictionary of medicines and devices (dm+d)
18 Dosage Calculations.
UNIT 9 The Medication Order.
WP1: D 1.3 Standards Framework Status June 25, 2015
Inaugural Expert Council Meeting at E.M.A. London June 25, 2015
13 September 2018 PHPID and its enabler role for identification of medicines for e-prescription Towards a trans-atlantic solution to univocally identify.
Medication Safety Dr. Kanar Hidayat
Closing the loop EPR-PHARMACY INTERFACE Bhulesh Vadher
NHS Scotland Clinical Models
Packaging After compounding packaging of prescription should be done.
PRESCRIPTIONS Chap. 5.
© Copyright Quicksilva 2005
Reviewed By- Dr Vijay Agarwal Dr Chander Mohan Bhagat Dr Lallu Joseph
HL7 Medication and UKCPRS
, editor October 8, 2011 DRAFT-D
Medication Safety Dr. Kanar Hidayat
APOLLOJAMES LECTURER NANDHA COLLEGE OF PHARMACY
Using Medicines Wisely
Grow Pharmacy Resources
Hospital pharmacy.
Presentation transcript:

HL7 Medication and UKCPRS Julie James Partner Blue Wave Informatics

HL7 Medication and UKCPRS HL7 Medication – Messaging about Medicines The Pharmacy D-MIM Describing the Medicine Using the dm+d (UKCPRS) to describe a Medicine in a Message

HL7 Medication – Messaging about Medicines Medication Information Special Interest Group (Med Info SIG) –Messaging about the Patient-Clinician-Medicine interaction –Prescribing medicines –Dispensing and supplying medicines –Administering medicines –Querying about individual patient’s medication(s) Patient Safety Special Interest Group –Messaging about Adverse Events that Medicines may cause (the “Yellow Card”) – the Individual Case Safety Report (ICSR) Regulatory and Clinical Research Information Management Technical Committee (RCRIM) –The “Structured Product Label” (representation of the Summary of Product Characteristics [SmPC] in a structured format, for clinical and regulatory use

The Pharmacy DMIM

Primary Care Prescription

Primary Care Dispensing

Secondary Care Prescribing

Secondary Care Administration

Describing the Medicine The Importance of the correctly describing a Medicine HL7 Information Model (the RIM) for messaging Realm-specific (use case driven) Terminology Model for description The need for Harmonisation The Medication CMETs (harmony, not melody)

Material Medicinal Product - Universal The medicine entity plays the role of “ordered medicine” Equivalent concepts (e.g. brand/generic) can be represented here The medicine’s ingredients can be represented using the role of “ingredient strength” and “ingredient” entities The medicine’s manufacturer can be represented using the role of “manufactured by” and “manufacturer” entity

Material Medicinal Product - Identified Just carry the dm+d identifier for the medicine in here

Material Medicinal Product Pack - Universal The supplied medicine entity plays the role of “supplied medication” The supplied medicine entity has batch number and expiry information; it will be a dm+d AMPP code The supplied medicine entity scopes the role of “pack of”

Material Medicinal Product Pack - Identified Just carry the dm+d identifier for the AMPP in here

Route of Administration & Dosage Information Mood = Request Effective time = when to give (frequency) Route code = dm+d route of administration code Dose quantity = how much of the medicine to give [Rate quantity – for a rate, rather than a unit dose] Additional textual instructions, if required

The UKCPRS Programme The “dm+d” – the NHS Dictionary of Medicines and Devices –Modelled vocabulary of medicinal product concepts –Supporting vocabulary of ingredient, dose forms, suppliers –Supporting vocabulary of dosage syntax (separate deliverable)

dm+d – a modelled vocabulary

The “Five Core Classes” of dm+d

Using the dm+d codes for Pharmacy CMETs ProposePromiseRequestEvent Medicine Entity Code (Ordered Medicine) VTM, VMP, VMPP, AMP, AMPP AMPP Supplied Medicine Entity Code (Supplied Medication) AMPP

dm+d – Supporting Attribute Vocabulary Dose Form vocabulary Ingredient vocabulary Route of Administration vocabulary Manufacturer or supplier vocabulary

Dosage Syntax A deliverable from a separate UKCPRS/HL7 Med Info SIG workstream –A standardised, modelled structure and vocabulary to describe medication dosage for electronic systems –Will “fit” into the Substance Administration act sections to message dosage instructions

Questions??? Thank you